Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intellipharmaceutics (IPCI)

Intellipharmaceutics (IPCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intellipharmaceutics 30 WORCESTER ROAD TORONTO A6 M9W 5X2 CAN

www.intellipharmaceutics.com P: 416-798-3001

Description:

IntelliPharmaCeutics International, Inc. was incorporated under the Canada Business Corporations Act by certificate and articles of arrangement dated October 22, 2009. The company engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company's lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. The company has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a generic of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy.

Key Statistics

Overview:

Market Capitalization, $K 4,618
Shares Outstanding, K 21,926
Annual Sales, $ 1,710 K
Annual Net Income, $ -13,750 K
Last Quarter Sales, $ 390 K
Last Quarter Net Income, $ -3,780 K
60-Month Beta 2.17
% of Institutional Shareholders 11.05%
Float, K 21,926
% Float 100.00%

Growth:

1-Year Return -96.60%
3-Year Return -98.99%
5-Year Return -99.50%
5-Year Revenue Growth 11.76%
5-Year Earnings Growth 35.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 04/15/19
Earnings Per Share ttm -3.18
EPS Growth vs. Prev Qtr 26.37%
EPS Growth vs. Prev Year 16.25%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/14/18

IPCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -188.63%
Profit Margin % -804.09%
Debt/Equity 0.00
Price/Sales 3.46
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share -0.43
Interest Coverage -51.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar